Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KYNTRA BIO, INC.
Report date September 07, 2021 · Filed September 10, 2021
Section 16 reporting ended · disclosed 2021-09-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 274,536 |
Reported balance
After 2021-09-07 transaction · row 1
1 source rowRow 1 · 2021-09-07 · Tax withholding · Disposed 2,141 · Balance 274,536 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 3,960 | $18.00 | $71,280.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 7 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $29.66 | $0.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · derivative · entry 11 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,136 Underlying: Common Stock · 22,000 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 23,540 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · derivative · entry 10 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,460 Underlying: Common Stock · 23,540 shares Expires 2024-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,700 | $56.94 | $210,678.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 6 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,852 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $56.85 to $57.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 23,730 | $56.29 | $1,335,761.70 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 5 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,552 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $55.85 to $56.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 16,210 | $55.35 | $897,223.50 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,282 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $54.85 to $55.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,900 | $54.50 | $103,550.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,492 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $53.85 to $54.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 22,000 | $29.66 | $652,520.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 22:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 23,540 | $18.00 | $423,720.00 |
DisclosureSEC source: 0001209191-18-010945 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Jan 25, 2018 01:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-18-005293 · doc4.xml · derivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 25,000 shares Expires 2024-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| January 22, 2018 Filed Jan 25, 2018 01:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 13,198 | $49.11 | $648,153.78 |
DisclosureSEC source: 0001209191-18-005293 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,852 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $48.80 to $49.35. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 22, 2018 Filed Jan 25, 2018 01:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 11,802 | $48.28 | $569,800.56 |
DisclosureSEC source: 0001209191-18-005293 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,050 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $47.80 to $48.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 22, 2018 Filed Jan 25, 2018 01:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 25,000 | $18.00 | $450,000.00 |
DisclosureSEC source: 0001209191-18-005293 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 14, 2017 00:10 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,851 | $46.00 | $131,146.00 |
DisclosureSEC source: 0001209191-17-065513 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,852 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 23:18 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,151 | $44.85 | $51,622.35 |
DisclosureSEC source: 0001209191-17-064833 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,703 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 01, 2017 Filed Dec 6, 2017 00:41 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,958 | $47.15 | $92,319.70 |
DisclosureSEC source: 0001209191-17-064068 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,854 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| November 09, 2017 Filed Nov 14, 2017 01:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,450 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-060480 · doc4.xml · derivative · entry 5 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550 Underlying: Common Stock · 6,450 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 09, 2017 Filed Nov 14, 2017 01:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-060480 · doc4.xml · derivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,600 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 09, 2017 Filed Nov 14, 2017 01:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-060480 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 09, 2017 Filed Nov 14, 2017 01:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,357 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-060480 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,357 shares Expires 2020-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 09, 2017 Filed Nov 14, 2017 01:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 32,407 | $2.90 | $93,980.30 |
DisclosureSEC source: 0001209191-17-060480 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:23 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,851 | $49.45 | $140,981.95 |
DisclosureSEC source: 0001209191-17-052698 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,405 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| September 06, 2017 Filed Sep 7, 2017 00:01 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,151 | $48.10 | $55,363.10 |
DisclosureSEC source: 0001209191-17-051803 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,256 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 01, 2017 Filed Sep 7, 2017 00:01 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,959 | $49.00 | $95,991.00 |
DisclosureSEC source: 0001209191-17-051803 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,407 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,254 Underlying: Common Stock · 85,000 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · derivative · entry 6 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 10,000 shares Expires 2021-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,707 | $51.28 | $292,654.96 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 5 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $51.20 to $51.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 78,304 | $50.69 | $3,969,229.76 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,073 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $50.20 to $51.175. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 10,989 | $49.70 | $546,153.30 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,377 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $49.20 to $50.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 85,000 | $14.58 | $1,238,875.00 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 23:14 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 10,000 | $3.50 | $35,000.00 |
DisclosureSEC source: 0001209191-17-048480 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,446 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · derivative · entry 10 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,254 Underlying: Common Stock · 9,446 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,300 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · derivative · entry 9 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,300 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 20,746 | $34.13 | $708,060.98 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 6 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $34.00 to $34.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 9,446 | $14.58 | $137,675.45 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 5 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 11,300 | $2.90 | $32,770.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 4 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $14.58 | $0.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · derivative · entry 8 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,700 Underlying: Common Stock · 300 shares Expires 2024-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,300 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · derivative · entry 7 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,300 Underlying: Common Stock · 7,300 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 7,600 | $33.54 | $254,904.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $33.45 to $34.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 300 | $14.58 | $4,372.50 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,966 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:16 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 7,300 | $2.90 | $21,170.00 |
DisclosureSEC source: 0001209191-17-047554 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2017 Filed Jul 7, 2017 20:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-044390 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,600 Underlying: Common Stock · 4,000 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 06, 2017 Filed Jul 7, 2017 20:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 4,000 | $34.00 | $136,000.00 |
DisclosureSEC source: 0001209191-17-044390 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| July 06, 2017 Filed Jul 7, 2017 20:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 4,000 | $2.90 | $11,600.00 |
DisclosureSEC source: 0001209191-17-044390 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 20:39 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-17-041681 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,600 Underlying: Common Stock · 3,000 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 20:39 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,000 | $32.00 | $96,000.00 |
DisclosureSEC source: 0001209191-17-041681 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 20:39 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 3,000 | $2.90 | $8,700.00 |
DisclosureSEC source: 0001209191-17-041681 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 22:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,500 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-041241 · doc4.xml · derivative · entry 3 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 22:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,500 | $30.00 | $165,000.00 |
DisclosureSEC source: 0001209191-17-041241 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,366 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 22:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,500 | $2.35 | $12,925.00 |
DisclosureSEC source: 0001209191-17-041241 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · VP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.